Is the treatment of Enterobius vermicularis co-infection necessary to eradicate Dientamoeba fragilis infection?
dc.creator | Boga J.A. | |
dc.creator | Rojo S. | |
dc.creator | Fernández J. | |
dc.creator | Rodríguez M. | |
dc.creator | Iglesias C. | |
dc.creator | Martínez-Camblor P. | |
dc.creator | Vázquez F. | |
dc.creator | Rodríguez-Guardado A. | |
dc.date.accessioned | 2020-09-02T22:13:32Z | |
dc.date.accessioned | 2022-11-08T20:24:43Z | |
dc.date.available | 2020-09-02T22:13:32Z | |
dc.date.available | 2022-11-08T20:24:43Z | |
dc.date.created | 2020-09-02T22:13:32Z | |
dc.date.issued | 2016 | |
dc.identifier | 49, , 59-61 | |
dc.identifier | 12019712 | |
dc.identifier | https://hdl.handle.net/20.500.12728/3782 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145369 | |
dc.language | en | |
dc.publisher | Elsevier B.V. | |
dc.subject | Dientamoeba fragilis | |
dc.subject | Enterobius vermicularis | |
dc.subject | Metronidazole | |
dc.subject | Parasite infection | |
dc.subject | Treatment | |
dc.subject | mebendazole | |
dc.subject | metronidazole | |
dc.subject | paromomycin | |
dc.subject | anthelmintic agent | |
dc.subject | antiprotozoal agent | |
dc.subject | mebendazole | |
dc.subject | metronidazole | |
dc.subject | adolescent | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | Article | |
dc.subject | asymptomatic disease | |
dc.subject | child | |
dc.subject | clinical article | |
dc.subject | clinical feature | |
dc.subject | consultation | |
dc.subject | dientamoebiasis | |
dc.subject | drug treatment failure | |
dc.subject | enterobiasis | |
dc.subject | Enterobius vermicularis | |
dc.subject | eradication therapy | |
dc.subject | female | |
dc.subject | human | |
dc.subject | immigrant | |
dc.subject | male | |
dc.subject | mixed infection | |
dc.subject | treatment response | |
dc.subject | animal | |
dc.subject | Coinfection | |
dc.subject | Dientamoeba | |
dc.subject | dientamoebiasis | |
dc.subject | drug effects | |
dc.subject | enterobiasis | |
dc.subject | Enterobius | |
dc.subject | feces | |
dc.subject | middle aged | |
dc.subject | parasitology | |
dc.subject | physiology | |
dc.subject | preschool child | |
dc.subject | young adult | |
dc.subject | Adolescent | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Animals | |
dc.subject | Anthelmintics | |
dc.subject | Antiprotozoal Agents | |
dc.subject | Child | |
dc.subject | Child, Preschool | |
dc.subject | Coinfection | |
dc.subject | Dientamoeba | |
dc.subject | Dientamoebiasis | |
dc.subject | Enterobiasis | |
dc.subject | Enterobius | |
dc.subject | Feces | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Mebendazole | |
dc.subject | Metronidazole | |
dc.subject | Middle Aged | |
dc.subject | Young Adult | |
dc.title | Is the treatment of Enterobius vermicularis co-infection necessary to eradicate Dientamoeba fragilis infection? | |
dc.type | Article |